Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychometric effect of topical lignocaine during awake fibreoptic intubation
ACTRN12610000459022Phase 4Not yet recruiting
- Sponsor
- Fremantle Hospital
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine, sponsored by Fremantle Hospital. Primary endpoints: Composite psychometric outcome, Complex reaction time test and 1 more. Planned start Jun 2010; status: not yet recruiting.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ACTRN12610000459022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000459022.